The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells

Esperanza Perucha,Rossella Melchiotti,Jack A Bibby,Wing Wu,Klaus Stensgaard Frederiksen,Ceri A. Roberts,Zoe Hall,Gaelle LeFriec,Kevin A. Robertson,Paul Lavender,Jens Gammeltoft Gerwien,Leonie S. Taams,Julian L. Griffin,Emanuele de Rinaldis,Lisa G. M. van Baarsen,Claudia Kemper,Peter Ghazal,Andrew P. Cope
DOI: https://doi.org/10.1038/s41467-019-08332-9
IF: 16.6
2019-01-30
Nature Communications
Abstract:The mechanisms controlling CD4+ T cell switching from an effector to an anti-inflammatory (IL-10+) phenotype play an important role in the persistence of chronic inflammatory diseases. Here, we identify the cholesterol biosynthesis pathway as a key regulator of this process. Pathway analysis of cultured cytokine-producing human T cells reveals a significant association between IL-10 and cholesterol metabolism gene expression. Inhibition of the cholesterol biosynthesis pathway with atorvastatin or 25-hydroxycholesterol during switching from IFNγ+ to IL-10+ shows a specific block in immune resolution, defined as a significant decrease in IL-10 expression. Mechanistically, the master transcriptional regulator of IL10 in T cells, c-Maf, is significantly decreased by physiological levels of 25-hydroxycholesterol. Strikingly, progression to rheumatoid arthritis is associated with altered expression of cholesterol biosynthesis genes in synovial biopsies of predisposed individuals. Our data reveal a link between sterol metabolism and the regulation of the anti-inflammatory response in human CD4+ T cells.
multidisciplinary sciences
What problem does this paper attempt to address?